Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results